Company: CI
Filing Date: 2025-10-30
Form Type: 10-Q
Source: 0001739940-25-000037
Chunk: 163

Company: Cigna Group
Filing Date: 2025-10-30
Form: 10-Q
Item: Part II, Item 7
Chunk 163
---
,380 3,889 13 12,412 10,862 14 Net investment income233 85 174 707 696 2 Total revenues69,748 63,694 10 202,428 181,472 12 Pharmacy and other service costs55,530 47,565 17 157,196 133,488 18 Medical costs and other benefit expenses7,842 9,527 (18)26,089 28,482 (8)Selling, general and administrative expenses3,362 3,590 (6)11,008 10,979 — Amortization of acquired intangible assets436 436 — 1,280 1,279 — Total benefits and expenses67,170 61,118 10 195,573 174,228 12 Income from operations2,578 2,576 — 6,855 7,244 (5)Interest expense and other(347)(376)(8)(1,046)(1,073)(3)Gain (loss) on sale of businesses38 (87)N/M79 (106)N/MNet investment gains (losses)26 (921)N/M76 (2,805)N/MIncome before income taxes2,295 1,192 93 5,964 3,260 83 Total income taxes322 367 (12)950 1,018 (7)Net income1,973 825 139 5,014 2,242 124 Less: Net income attributable to noncontrolling interests105 86 22 291 232 25 Shareholders' net income$1,868 $739 153 %$4,723 $2,010 135 %Consolidated effective tax rate14.0 %30.8 %(1,680)bps15.9 %31.2 %(1,530)bpsMedical customers (in thousands)18,059 19,048 (5)%

36

Reconciliation of Shareholders' Net Income (GAAP) to Adjusted Income from OperationsThree Months Ended September 30,Nine Months Ended September 30,2025202420252024(In millions)Pre-taxAfter-taxPre-taxAfter-taxPre-taxAfter-taxPre-taxAfter-taxShareholders' net income$1,868